Cockerell G L, O'Donnell R W, Zgola M M
Cancer Immunol Immunother. 1982;13(3):198-204. doi: 10.1007/BF00205389.
The immunological and pathological responses of guinea pigs to an intramural colonic injection of emulsions containing cell wall (CW) extracts of Mycobacterium bovis BCG and mineral oil were studied from week 1 to week 36 post-inoculation. The emulsions contained variable concentrations of BCG CW attached to (lipid-phase), or separate from (aqueous-phase), the mineral oil. Delayed cutaneous hypersensitivity to PPD was present throughout the course of the study in a variable percentage of guinea pigs inoculated with either type of emulsion. PPD-induced blast transformation of peripheral blood lymphocytes, studied in guinea pigs which received lipid-phase emulsion, was also detectable throughout the course of the study, with maximal response seen 2 weeks post-inoculation. The intracolonic inoculations were well tolerated, with the exception of the most concentrated lipid-phase emulsion (3 mg/ml BCG CW and 5% oil), after which one of eight guinea pigs died due to a colonic impaction and rupture at the site of inoculation. The pathological response to either type of emulsion was a focal granulomatous colitis, which tended to be more severe as the concentration of BCG CW and oil increased. Extracolonic lesions were usually limited to a granulomatous lymphadenitis of lymph nodes draining the injection site; however, the most concentrated lipid-phase emulsion occasionally produced granulomatous inflammatory foci in the liver and lungs. In general, the lesions induced by the lipid-phase emulsions were more severe than those induced by aqueous-phase emulsions, but the intensity of both types of lesions peaked at 2 or 4 weeks post-inoculation. It was concluded that the guinea pig may serve as a useful model to study BCG immunotherapy of colonic neoplasms, since intracolonic injection of BCG CW resulted in systemic immunity toward mycobacterial antigens and a localized accumulation of macrophages without untoward complications.
在接种后第1周~第36周,研究了豚鼠对结肠壁内注射含牛分枝杆菌卡介苗细胞壁(CW)提取物与矿物油的乳剂的免疫和病理反应。这些乳剂含有与矿物油附着(脂质相)或分离(水相)的不同浓度的卡介苗CW。在整个研究过程中,接种任一种乳剂的豚鼠中,有不同比例的豚鼠出现对结核菌素纯蛋白衍生物(PPD)的迟发型皮肤超敏反应。在接受脂质相乳剂的豚鼠中研究发现,整个研究过程中也可检测到PPD诱导的外周血淋巴细胞增殖转化,接种后2周出现最大反应。除了最浓缩的脂质相乳剂(3mg/ml卡介苗CW和5%油)外,结肠内接种耐受性良好,接种该乳剂后,8只豚鼠中有1只因接种部位结肠梗阻和破裂死亡。对任一种乳剂的病理反应均为局灶性肉芽肿性结肠炎,随着卡介苗CW和油浓度的增加,病情往往更严重。结肠外病变通常局限于引流注射部位的淋巴结的肉芽肿性淋巴结炎;然而,最浓缩的脂质相乳剂偶尔会在肝脏和肺中产生肉芽肿性炎症病灶。一般来说,脂质相乳剂诱导的病变比水相乳剂诱导的病变更严重,但两种病变的强度在接种后2周或4周达到峰值。结论是,豚鼠可作为研究结肠肿瘤卡介苗免疫治疗的有用模型,因为结肠内注射卡介苗CW可产生针对分枝杆菌抗原的全身免疫和巨噬细胞的局部聚集,且无不良并发症。